ArticleCancer cell2021
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
Abstract readPublished Erratum
In one paragraph
Article in Cancer cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.
0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed.
- Activated hepatic stellate cell-derived exosomal miR-23a-3p promotes hepatocellular carcinogenesis by regulating DUSP5/ERK signaling.Journal of advanced research · 2026Article
- Cholangiocarcinoma:Unveiling the cold tumor microenvironment and strategies for immune rejuvenation.Oncogene · 2026Review
- Article
- Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective.European journal of nuclear medicine and molecular imaging · 2026Review
- Multi-omics profiling reveals that ScissorCellular oncology (Dordrecht, Netherlands) · 2026Article
- OLFM4 promotes intrahepatic cholangiocarcinoma progression through a PKM2-glycolysis-histone lactylation feedback loop.International journal of biological sciences · 2026Article
- Mesothelin/Mucin 16 Signaling in Activated Portal Fibroblasts Drives the Development of Cholestatic Fibrosis and Hepatocellular Carcinoma in Aged Female Multidrug Resistance Protein 2 Knockout Mice.Cellular and molecular gastroenterology and hepatology · 2026Article
- Insights into the relevance of targeting fibroblasts to control cancer.Cell reports. Medicine · 2025Review
- Single-cell multi-omics in biliary tract cancers: decoding heterogeneity, microenvironment, and treatment strategies.Molecular biomedicine · 2025Review
- Pericytes in hematogenous metastasis: mechanistic insights and therapeutic approaches.Cellular oncology (Dordrecht, Netherlands) · 2025Review
- Association of α-SMA/FAP-positive cancer-associated fibroblasts with clinicopathological features and prognosis in extrahepatic cholangiocarcinoma.Diagnostic pathology · 2025Article
- Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease.Nature reviews. Gastroenterology & hepatology · 2025Review
- POU6F2 promotes liver metastasis of gastric adenocarcinoma by dual mechanism of transcriptional upregulation of SNAI1 and IGF2/PI3K/AKT signaling-induced conversion of hepatic stellate cells into cancer-associated fibroblasts.British journal of cancer · 2025Article
- Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy.Journal of hematology & oncology · 2025Review
- Periductal fibroblasts participate in liver homeostasis, fibrosis, and tumorigenesis.The Journal of experimental medicine · 2025Article
- Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights.APL bioengineering · 2025Review
- Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.Journal of hematology & oncology · 2025Review
- Comprehensive analysis of SQOR involvement in ferroptosis resistance of pancreatic ductal adenocarcinoma in hypoxic environments.Frontiers in immunology · 2025Article
- Transposon-based oncogene integration in Abcb4(Mdr2)Journal of hepatology · 2025Article
- Single-cell and spatial transcriptomics integration: new frontiers in tumor microenvironment and cellular communication.Frontiers in immunology · 2025Review
Corrections and comments
- Erratum for
Authors and funding
37 authors.
Silvia Affo
Ajay Nair
Francesco Brundu
Aashreya Ravichandra
Sonakshi Bhattacharjee
Michitaka Matsuda
LiKang Chin
Aveline Filliol
Wen Wen
Xinhua Song
Aubrianna Decker
Jeremy Worley
Jorge Matias Caviglia
Lexing Yu
Deqi Yin
Yoshinobu Saito
Thomas Savage
Rebecca G Wells
Matthias Mack
Lars Zender
Nicholas Arpaia
Helen E Remotti
Raul Rabadan
Peter Sims
Anne-Laure Leblond
Achim Weber
Marc-Oliver Riener
Brent R Stockwell
Jellert Gaublomme
Josep M Llovet
Raghu Kalluri
George K Michalopoulos
Ekihiro Seki
Daniela Sia
Xin Chen
Andrea Califano
Robert F Schwabe
Funding
Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca A Simmons · 2006 to 2026
$35.3MRole of Cancer-Associated Fibroblasts in CholangiocarcinomaR01CA228483 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHEN, XIN, SCHWABE, ROBERT F. · 2018 to 2022
$3.1MTAZ and YAP in Non-Alcoholic Steatohepatitis and its ComplicationsR01DK116620 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F., TABAS, IRA A · 2018 to 2021
$2.7MHMGB1 as Link Between Hepatocellular Injury and HCCR01CA200597 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F. · 2016 to 2020
$2.2MDAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver FibrosisR01DK124104 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F. · 2019 to 2022
$2.1MRole of the Gut Microbiota and TLR4 in Alcoholic HepatocarcinogenesisR01AA020211 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F. · 2010 to 2014
$2.0MSignaling cascades in cholangiocarcinoma developmentR01CA190606 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, XIN · 2016 to 2020
$1.8MHepatic Stellate Cells and Liver CancerR01CA190844 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F. · 2015 to 2019
$1.8MToll-Like Receptor Signaling in Hepatic FibrogenesisR01DK076920 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F. · 2008 to 2012
$1.5MThe Endocannabinoid System in hepatic Injury and FibrosisR01DK075830 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHWABE, ROBERT F. · 2007 to 2011
$1.3MNCI NIH HHS R01 CA190606NCI NIH HHS R01 CA190844NCI NIH HHS R01 CA200597NCI NIH HHS R01 CA228483NIAAA NIH HHS R01 AA020211NIDDK NIH HHS R01 DK075830NIDDK NIH HHS R01 DK076920NIDDK NIH HHS R01 DK116620NIDDK NIH HHS R01 DK124104NIEHS NIH HHS P30 ES013508
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.